Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03615690 · ClinicalTrials.gov registry record · NA
The Influence of a Fasting Mimicking Diet on Ulcerative Colitis
A NA study of Ulcerative Colitis and Inflammatory Bowel Disease, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT03615690 is a NA study of Ulcerative Colitis and Inflammatory Bowel Disease that is actively recruiting participants, run by Stanford University. The registered enrollment target is 75 participants, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03615690, a NA study of Ulcerative Colitis and Inflammatory Bowel Disease, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see how a diet that mimics fasting effects inflammation in patients with mild to moderate Ulcerative Colitis (UC). The diet may allow users to receive the benefits of fasting while also being able to enjoy food (the ingredients of which are GRAS (generally recognized as safe) by the Food and Drug Administration (FDA). Research on dietary interventions and UC are very limited. Fasting mimicking diets (FMD) have been studied with support of the National Institute of Health and published in leading journals. This research investigates whether markers of inflammation decrease and/or quality of life increases after three cycles of a five-day period of the fasting mimicking diet, and may provide rationale for its use to treat UC.
Conditions Studied
Interventions
- OTHER Regular Diet
- OTHER Fasting Mimicking Diet
Study Locations (1)
California
- Stanford University - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2020-12-15 |
| Est. Completion | 2028-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03615690
The ClinicalTrials.gov registry entry for NCT03615690 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (96% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Ulcerative Colitis appearing as the primary indexed condition, and to 2 interventions - of which Regular Diet is the first listed.
NCT03615690 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03615690 about?
NCT03615690 is a clinical study titled "The Influence of a Fasting Mimicking Diet on Ulcerative Colitis". The purpose of this study is to see how a diet that mimics fasting effects inflammation in patients with mild to moderate Ulcerative Colitis (UC). The diet may allow users to receive the benefits of fasting while also being able to enjoy food (the ingredients of which are GRAS (generally recognized ...
What is the current status of trial NCT03615690?
This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2020-12-15. Estimated completion is 2028-12.
What conditions does trial NCT03615690 study?
This clinical trial studies the following conditions: Ulcerative Colitis, Inflammatory Bowel Disease, Diet Modification.
What interventions are being tested in trial NCT03615690?
The interventions under investigation include: Regular Diet (OTHER), Fasting Mimicking Diet (OTHER).
Who is sponsoring clinical trial NCT03615690?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03615690 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ulcerative Colitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
RECRUITING · NA
-
A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis
RECRUITING · NA
-
Nicotinamide Riboside in Ulcerative Colitis
RECRUITING · NA
-
Fermented Food-Supplemented Diet in Ulcerative Colitis
RECRUITING · NA
-
Impact of Prebiotics in Ulcerative Colitis
RECRUITING · NA
-
Tailored Anti-Inflammatory (A-I) Diet for Americans With Ulcerative Colitis (UC)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.